Article Contents ::
Details About Generic Salt :: Alfacalcidol
Main Medicine Class:: Endocrine,Steroid Hormones , Metabolic System Sub Medicine Class :: Drugs affecting Bone Metabolism
| 8I. DRUGS AFFECTING BONE METABOLISM in 8. ENDOCRINE/STEROID HORMONES & METABOLIC SYSTEM |
| ALFACALCIDOL |
| VIT D ANALOG | DRUGS AFFECTING BONE METABOLISM |
| PK: M: Hepatic |
|
Indications & Dose: HYPOCALCEMIA PO Adult Initially 1µg/day, MD 0.25-1µg/day Child Premature infants & neonates: 0.05-0.1µg/kg/day, Children(<20 kg): 0.05µg/kg/day Elderly Initially 0.5µg/day, MD 0.25-1 µg/day | HYPOPARATHYROIDISM PO Adult Initially 1µg/day; MD 0.25-1µg/day Child Premature infants & neonates: 0.05-0.1µg/kg/day Children(<20 kg): 0.05µg/kg/day Elderly Initially 0.5µg/day; MD 0.25-1 µg/day | HYPOPHOSPHATEMIA PO Adult Initially 1µg/day; MD 0.25-1µg/day Child Premature infants & neonates: 0.05-0.1µg/kg/day Children(<20 kg): 0.05µg/kg/day Elderly Initially 0.5µg/day; MD 0.25-1 µg/day | OSTEOMALACIA PO Adult Initially 1µg/day; MD 0.25-1µg/day Child Premature infants & neonates: 0.05-0.1µg/kg/day Children(<20 kg): 0.05µg/kg/day Elderly Initially 0.5µg/day; MD 0.25-1 µg/day | PREVENTION OF VIT D DEFICIENCY IN RENAL/CHOLESTATIC LIVER DISEASE PO/IV Child Neonate: 0.02µg/kg OD, 1 month-12 yr (<20 kg): 0.015-0.03µg/kg OD (max 0.5µg), >20 kg: 0.25-0.5µg OD, 12-18 yr:0.25-0.5µg OD | RENAL OSTEODYSTROPHY PO Adult Predialysis: Initially 0.25µg/day 2 months, increase by 0.25µg/day q2months; MD: 0.5-1µg/day Dialysis:Initially 1µg/day 4 wks, increase by 0.5µg/day q2-4 wks; MD: 0.25-1µg/day | IV Adult Dialysis patients: Initially 1µg/dialysis (max 12µg/wk); MD: 1.5-12µg/wk | RICKETS PO Adult Initially 1µg/day; MD 0.25-1µg/day Child Premature infants & neonates: 0.05-0.1µg/kg/day Children(<20 kg): 0.05µg/kg/day Elderly Initially 0.5µg/day; MD 0.25-1 µg/day | SECONDARY HYPERPARATHYROIDISM PO Adult Initially 1µg/day; MD 0.25-1µg/day Child Premature infants & neonates: 0.05-0.1µg/kg/day; <20 kg: 0.05µg/kg/day Elderly Initially 0.5µg/day; MD 0.25-1µg/day |
| Contra: Hypersensitivity, hypercalcemia/hyperphosphatemia
Precautions: Renal impairment/calculi/heart disease, infants ADR: Serious: cardiac arrhythmia, HTN, Others: headache, hyperthermia, pruritus, nocturia, hypercalcemia, hypercholesterolemia, anorexia, constipation, nausea, vomiting, hepatic enzyme elevated, myalgia, conjunctivitis, BUN elevated, polyuria, rhinorrhea DDI: Serious Digoxin results in arrhythmias Diet: With food Monitor: Serum Ca, phosphate, Cr, BUN, albumin |
